Mehta Kamal D, Radominska-Pandya Anna, Kapoor Gurpreet S, Dave Bhuvanesh, Atkins Brett A
Department of Molecular and Cellular Biochemistry, The Ohio State University College of Medicine, Columbus, Ohio 43210, USA.
Mol Cell Biol. 2002 Jun;22(11):3783-93. doi: 10.1128/MCB.22.11.3783-3793.2002.
Induction of low-density lipoprotein (LDL) receptor transcription in response to depletion of cellular sterols in animal cells is well established. The intracellular signal or signals involved in regulating this process, however, remain unknown. Using a specific inhibitor of protein kinase C (PKC), calphostin C, we show the requirement of this kinase in the induction process in human hepatoma HepG2 cells. Overexpression of PKC epsilon, but not PKC alpha, -gamma, -delta, or -zeta was found to dramatically induce (approximately 18-fold) LDL receptor promoter activity. Interestingly, PKC epsilon-mediated induction was found to be sterol resistant. To further establish that PKC epsilon is involved in the sterol regulation of LDL receptor gene transcription, endogenous PKC epsilon was specifically inhibited by transfection with antisense PKC epsilon phosphorothionate oligonucleotides. Antisense treatment decreased endogenous PKC epsilon protein levels and completely blocked induction of LDL receptor transcription following sterol depletion. PKC epsilon-induced LDL receptor transcription is independent of the extracellular signal-regulated kinase 1 and 2 (p42/44(MAPK)) cascade, because the MEK-1/2 inhibitor, PD98059 did not inhibit, even though it blocked p42/44(MAPK) activation. Finally, photoaffinity labeling studies showed an isoform-specific interaction between PKC epsilon and sterols, suggesting that sterols may directly modulate its function by hampering binding of activators. This was confirmed by PKC activity assays. Altogether, these results define a novel signaling pathway leading to induction of LDL receptor transcription following sterol depletion, and a model is proposed to account for a new function for PKC epsilon as part of a sterol-sensitive signal transduction pathway in hepatic cells.
动物细胞中,低密度脂蛋白(LDL)受体转录因细胞内固醇耗竭而被诱导,这一点已得到充分证实。然而,参与调节这一过程的细胞内信号仍不明确。我们使用蛋白激酶C(PKC)的特异性抑制剂钙泊三醇,证明了该激酶在人肝癌HepG2细胞诱导过程中的必要性。研究发现,过表达PKCε而非PKCα、-γ、-δ或-ζ可显著诱导(约18倍)LDL受体启动子活性。有趣的是,PKCε介导的诱导具有固醇抗性。为进一步证实PKCε参与LDL受体基因转录的固醇调节,通过转染反义PKCε硫代磷酸酯寡核苷酸特异性抑制内源性PKCε。反义处理降低了内源性PKCε蛋白水平,并完全阻断了固醇耗竭后LDL受体转录的诱导。PKCε诱导的LDL受体转录独立于细胞外信号调节激酶1和2(p42/44(MAPK))级联反应,因为MEK-1/2抑制剂PD98059虽可阻断p42/44(MAPK)激活,但并未抑制该反应。最后,光亲和标记研究显示PKCε与固醇之间存在异构体特异性相互作用,表明固醇可能通过阻碍激活剂结合直接调节其功能。PKC活性测定证实了这一点。总之,这些结果确定了一条新的信号通路,该通路在固醇耗竭后导致LDL受体转录的诱导,并提出了一个模型,以解释PKCε作为肝细胞中固醇敏感信号转导通路一部分所具有的新功能。